ID GEA2_YEAST Reviewed; 1459 AA. AC P39993; D3DLM6; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 1. DT 27-MAR-2024, entry version 194. DE RecName: Full=ARF guanine-nucleotide exchange factor 2; GN Name=GEA2; OrderedLocusNames=YEL022W; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169868; RA Dietrich F.S., Mulligan J.T., Hennessy K.M., Yelton M.A., Allen E., RA Araujo R., Aviles E., Berno A., Brennan T., Carpenter J., Chen E., RA Cherry J.M., Chung E., Duncan M., Guzman E., Hartzell G., Hunicke-Smith S., RA Hyman R.W., Kayser A., Komp C., Lashkari D., Lew H., Lin D., Mosedale D., RA Nakahara K., Namath A., Norgren R., Oefner P., Oh C., Petel F.X., RA Roberts D., Sehl P., Schramm S., Shogren T., Smith V., Taylor P., Wei Y., RA Botstein D., Davis R.W.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome V."; RL Nature 387:78-81(1997). RN [2] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [3] RP CHARACTERIZATION. RX PubMed=8945477; DOI=10.1038/384479a0; RA Peyroche A., Paris S., Jackson C.L.; RT "Nucleotide exchange on ARF mediated by yeast Gea1 protein."; RL Nature 384:479-481(1996). RN [4] RP INTERACTION WITH GMH1, AND SUBCELLULAR LOCATION. RX PubMed=12808035; DOI=10.1091/mbc.e02-10-0693; RA Chantalat S., Courbeyrette R., Senic-Matuglia F., Jackson C.L., Goud B., RA Peyroche A.; RT "A novel Golgi membrane protein is a partner of the ARF exchange factors RT Gea1p and Gea2p."; RL Mol. Biol. Cell 14:2357-2371(2003). RN [5] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [6] RP INTERACTION WITH DRS2, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND RP MUTAGENESIS OF VAL-698. RX PubMed=14734650; DOI=10.1242/jcs.00896; RA Chantalat S., Park S.K., Hua Z., Liu K., Gobin R., Peyroche A., RA Rambourg A., Graham T.R., Jackson C.L.; RT "The Arf activator Gea2p and the P-type ATPase Drs2p interact at the Golgi RT in Saccharomyces cerevisiae."; RL J. Cell Sci. 117:711-722(2004). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ADR376; RX PubMed=17330950; DOI=10.1021/pr060559j; RA Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., RA Elias J.E., Gygi S.P.; RT "Large-scale phosphorylation analysis of alpha-factor-arrested RT Saccharomyces cerevisiae."; RL J. Proteome Res. 6:1190-1197(2007). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-284, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [9] RP FUNCTION, AND MUTAGENESIS OF VAL-698. RX PubMed=19898464; DOI=10.1038/ncb1989; RA Natarajan P., Liu K., Patil D.V., Sciorra V.A., Jackson C.L., Graham T.R.; RT "Regulation of a Golgi flippase by phosphoinositides and an ArfGEF."; RL Nat. Cell Biol. 11:1421-1426(2009). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19779198; DOI=10.1126/science.1172867; RA Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.; RT "Global analysis of Cdk1 substrate phosphorylation sites provides insights RT into evolution."; RL Science 325:1682-1686(2009). RN [11] RP FUNCTION. RX PubMed=25190516; DOI=10.15252/embj.201489039; RA Ackema K.B., Hench J., Boeckler S., Wang S.C., Sauder U., Mergentaler H., RA Westermann B., Bard F., Frank S., Spang A.; RT "The small GTPase Arf1 modulates mitochondrial morphology and function."; RL EMBO J. 33:2659-2675(2014). RN [12] RP X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 558-766 IN COMPLEX WITH GDP AND RP SEC7. RX PubMed=11888276; DOI=10.1021/bi012123h; RA Renault L., Christova P., Guibert B., Pasqualato S., Cherfils J.; RT "Mechanism of domain closure of Sec7 domains and role in BFA sensitivity."; RL Biochemistry 41:3605-3612(2002). CC -!- FUNCTION: Activates the ARF proteins by exchanging bound GDP for free CC GTP. Plays a role in maintaining mitochondrial morphology CC (PubMed:25190516). Stimulates DRS2 flippase activity (PubMed:19898464). CC {ECO:0000269|PubMed:19898464, ECO:0000269|PubMed:25190516}. CC -!- SUBUNIT: Interacts (via SEC7 domain) with DRS2 (via C-terminus); the CC interaction is direct (PubMed:14734650). Interacts with GMH1 CC (PubMed:11888276, PubMed:12808035). {ECO:0000269|PubMed:11888276, CC ECO:0000269|PubMed:12808035, ECO:0000269|PubMed:14734650}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12808035, CC ECO:0000269|PubMed:14734650}. Membrane {ECO:0000269|PubMed:12808035}; CC Peripheral membrane protein {ECO:0000269|PubMed:12808035}. Golgi CC apparatus membrane {ECO:0000269|PubMed:14734650}; Peripheral membrane CC protein {ECO:0000269|PubMed:12808035}. Note=Soluble and partially CC membrane-bound (PubMed:12808035, PubMed:14734650). Associates with CC early and late Golgi compartments (PubMed:14734650). CC {ECO:0000269|PubMed:12808035, ECO:0000269|PubMed:14734650}. CC -!- DISRUPTION PHENOTYPE: Exacerbates the cold sensitivity of a DRS2- CC knockout. {ECO:0000269|PubMed:14734650}. CC -!- MISCELLANEOUS: Present with 7700 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U18530; AAB64499.1; -; Genomic_DNA. DR EMBL; BK006939; DAA07630.1; -; Genomic_DNA. DR PIR; S50437; S50437. DR RefSeq; NP_010892.1; NM_001178837.1. DR PDB; 1KU1; X-ray; 1.93 A; A/B=558-766. DR PDB; 7URO; EM; 4.20 A; A/C=1-1459. DR PDB; 7URR; EM; 4.70 A; A/B=1-1459. DR PDB; 7UT4; EM; 3.90 A; A/B=1-1459. DR PDB; 7UTH; EM; 3.90 A; A/B=1-1459. DR PDB; 8EZJ; EM; 3.30 A; A/B=1-1459. DR PDB; 8EZQ; EM; 3.70 A; A/B=1-1459. DR PDBsum; 1KU1; -. DR PDBsum; 7URO; -. DR PDBsum; 7URR; -. DR PDBsum; 7UT4; -. DR PDBsum; 7UTH; -. DR PDBsum; 8EZJ; -. DR PDBsum; 8EZQ; -. DR AlphaFoldDB; P39993; -. DR EMDB; EMD-28743; -. DR EMDB; EMD-28748; -. DR SMR; P39993; -. DR BioGRID; 36707; 66. DR DIP; DIP-6816N; -. DR IntAct; P39993; 16. DR STRING; 4932.YEL022W; -. DR CarbonylDB; P39993; -. DR GlyGen; P39993; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; P39993; -. DR MaxQB; P39993; -. DR PaxDb; 4932-YEL022W; -. DR PeptideAtlas; P39993; -. DR EnsemblFungi; YEL022W_mRNA; YEL022W; YEL022W. DR GeneID; 856691; -. DR KEGG; sce:YEL022W; -. DR AGR; SGD:S000000748; -. DR SGD; S000000748; GEA2. DR VEuPathDB; FungiDB:YEL022W; -. DR eggNOG; KOG0928; Eukaryota. DR GeneTree; ENSGT00940000176690; -. DR HOGENOM; CLU_001204_0_1_1; -. DR InParanoid; P39993; -. DR OMA; ILWTRSP; -. DR OrthoDB; 204547at2759; -. DR BioCyc; YEAST:G3O-30146-MONOMER; -. DR Reactome; R-SCE-199992; trans-Golgi Network Vesicle Budding. DR Reactome; R-SCE-5620916; VxPx cargo-targeting to cilium. DR Reactome; R-SCE-6807878; COPI-mediated anterograde transport. DR Reactome; R-SCE-6811434; COPI-dependent Golgi-to-ER retrograde traffic. DR BioGRID-ORCS; 856691; 10 hits in 10 CRISPR screens. DR EvolutionaryTrace; P39993; -. DR PRO; PR:P39993; -. DR Proteomes; UP000002311; Chromosome V. DR RNAct; P39993; Protein. DR GO; GO:0005829; C:cytosol; HDA:SGD. DR GO; GO:0000137; C:Golgi cis cisterna; IDA:SGD. DR GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:SGD. DR GO; GO:0030036; P:actin cytoskeleton organization; IGI:SGD. DR GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; IMP:SGD. DR GO; GO:0006891; P:intra-Golgi vesicle-mediated transport; IMP:SGD. DR GO; GO:0016236; P:macroautophagy; IMP:SGD. DR GO; GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro. DR GO; GO:0006890; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; IGI:SGD. DR GO; GO:0033363; P:secretory granule organization; IMP:SGD. DR CDD; cd00171; Sec7; 1. DR Gene3D; 1.10.220.20; -; 1. DR Gene3D; 1.10.1000.11; Arf Nucleotide-binding Site Opener,domain 2; 1. DR InterPro; IPR032691; Mon2/Sec7/BIG1-like_HUS. DR InterPro; IPR023394; Sec7_C_sf. DR InterPro; IPR000904; Sec7_dom. DR InterPro; IPR035999; Sec7_dom_sf. DR PANTHER; PTHR10663:SF388; GOLGI-SPECIFIC BREFELDIN A-RESISTANCE GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; 1. DR PANTHER; PTHR10663; GUANYL-NUCLEOTIDE EXCHANGE FACTOR; 1. DR Pfam; PF01369; Sec7; 1. DR Pfam; PF12783; Sec7-like_HUS; 1. DR SMART; SM00222; Sec7; 1. DR SUPFAM; SSF48425; Sec7 domain; 1. DR PROSITE; PS50190; SEC7; 1. PE 1: Evidence at protein level; KW 3D-structure; Cytoplasm; Golgi apparatus; KW Guanine-nucleotide releasing factor; Membrane; Phosphoprotein; KW Reference proteome. FT CHAIN 1..1459 FT /note="ARF guanine-nucleotide exchange factor 2" FT /id="PRO_0000120213" FT DOMAIN 570..714 FT /note="SEC7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00189" FT REGION 1412..1459 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1443..1459 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 46 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT MOD_RES 284 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17330950, FT ECO:0007744|PubMed:18407956, ECO:0007744|PubMed:19779198" FT MUTAGEN 698 FT /note="V->G: Abolishes interaction with DRS2 and decreases FT DRS2 phosphatidylserine flippase activity in the FT trans-Golgi network membrane. Abnormal secretory vesicle FT formation." FT /evidence="ECO:0000269|PubMed:14734650" FT HELIX 558..572 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 574..583 FT /evidence="ECO:0007829|PDB:1KU1" FT STRAND 586..588 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 592..601 FT /evidence="ECO:0007829|PDB:1KU1" FT TURN 602..605 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 608..615 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 618..620 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 621..629 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 638..645 FT /evidence="ECO:0007829|PDB:1KU1" FT TURN 646..648 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 655..671 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 677..679 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 688..690 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 695..712 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 723..729 FT /evidence="ECO:0007829|PDB:1KU1" FT TURN 730..732 FT /evidence="ECO:0007829|PDB:1KU1" FT HELIX 741..753 FT /evidence="ECO:0007829|PDB:1KU1" SQ SEQUENCE 1459 AA; 165668 MW; 99DB9FDD34F863FA CRC64; MSDREFVTVD PVTIIIKECI NLSTAMRKYS KFTSQSGVAA LLGGGSEIFS NQDDYLAHTF NNLNTNKHND PFLSGFIQLR LMLNKLKNLD NIDSLTILQP FLLIVSTSSI SGYITSLALD SLQKFFTLNI INESSQNYIG AHRATVNALT HCRFEGSQQL SDDSVLLKVV FLLRSIVDSP YGDLLSNSII YDVLQTILSL ACNNRRSEVL RNAAQSTMIA VTVKIFSKLK TIEPVNVNQI YINDESYTND VLKADTIGTN VESKEEGSQE DPIGMKVNNE EAISEDDGIE EEHIHSEKST NGAEQLDIVQ KTTRSNSRIQ AYADDNYGLP VVRQYLNLLL SLIAPENELK HSYSTRIFGL ELIQTALEIS GDRLQLYPRL FTLISDPIFK SILFIIQNTT KLSLLQATLQ LFTTLVVILG NNLQLQIELT LTRIFSILLD DGTANNSSSE NKNKPSIIKE LLIEQISILW TRSPSFFTST FINFDCNLDR ADVSINFLKA LTKLALPESA LTTTESVPPI CLEGLVSLVD DMFDHMKDID REEFGRQKNE MEILKKRDRK TEFIECTNAF NEKPKKGIPM LIEKGFIASD SDKDIAEFLF NNNNRMNKKT IGLLLCHPDK VSLLNEYIRL FDFSGLRVDE AIRILLTKFR LPGESQQIER IIEAFSSAYC ENQDYDPSKI SDNAEDDIST VQPDADSVFI LSYSIIMLNT DLHNPQVKEH MSFEDYSGNL KGCCNHKDFP FWYLDRIYCS IRDKEIVMPE EHHGNEKWFE DAWNNLISST TVITEIKKDT QSVMDKLTPL ELLNFDRAIF KQVGPSIVST LFNIYVVASD DHISTRMITS LDKCSYISAF FDFKDLFNDI LNSIAKGTTL INSSHDDELS TLAFEYGPMP LVQIKFEDTN TEIPVSTDAV RFGRSFKGQL NTVVFFRIIR RNKDPKIFSK ELWLNIVNII LTLYEDLILS PDIFPDLQKR LKLSNLPKPS PEISINKSKE SKGLLSTFAS YLKGDEEPTE EEIKSSKKAM ECIKSSNIAA SVFGNESNIT ADLIKTLLDS AKTEKNADNS RYFEAELLFI IELTIALFLF CKEEKELGKF ILQKVFQLSH TKGLTKRTVR RMLTYKILLI SLCADQTEYL SKLINDELLK KGDIFTQKFF ATNQGKEFLK RLFSLTESEF YRGFLLGNEN FWKFLRKVTA MKEQSESIFE YLNESIKTDS NILTNENFMW VLGLLDEISS MGAVGNHWEI EYKKLTESGH KIDKENPYKK SIELSLKSIQ LTSHLLEDNN DLRKNEIFAI IQALAHQCIN PCKQISEFAV VTLEQTLINK IEIPTNEMES VEELIEGGLL PLLNSSETQE DQKILISSIL TIISNVYLHY LKLGKTSNET FLKILSIFNK FVEDSDIEKK LQQLILDKKS IEKGNGSSSH GSAHEQTPES NDVEIEATAP IDDNTDDDNK PKLSDVEKD //